In Memory of our Co-founder Tom Isaacs

Tom Isaacs - our President and Co-founder - died unexpectedly on 31st May. Tom was and is the charity's inspiration and his passing is devastating. However - his determination to help find a cure for everyone living with Parkinson’s remains THE mission of this incredible charity and we are more determined than ever to fulfil his vision... Read more

Support our Linked Clinical Trials Programme

The LCT programme is spearheaded by The Cure Parkinson's Trust to prioritise and fast-track drugs, currently used to treat other conditions, with the potential to slow, stop, or reverse Parkinson's. Read more

GLP-1 Agonists - donate to fund this promising research

Liraglutide, Lixisenatide, Exenatide and Bydureon belong to a group of safe and well-tolerated drugs called GLP-1 agonists. They are used to treat type 2 diabetes and in recent years there has been research based evidence to suggest that they show great promise as a new treatment for Parkinson's. Read more